ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concepts For Three Radiation Research RFAs

March 6, 1987

IOM Appoints 17 To National Cancer Policy Board

February 7, 1997

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999

Cancer Control, Smoking Programs Reorganized

December 7, 1990

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

November 29, 2002

Letter: Headline Criticized On Letter About Consortium

June 21, 1996